Why the study?
Do amitriptyline, mianserin, zimelidine, and nomifensine alter systolic time intervals and ECG parameters in depressed patients?
Do amitriptyline, mianserin, zimelidine, and nomifensine alter systolic time intervals and ECG parameters in depressed patients?
Amitriptyline decreases cardiac contractility and exhibits quinidine-like effects, whereas mianserin's cardiovascular changes are likely due to peripheral circulation effects.
Answers are grounded in this paper and cite their sources.
Amitriptyline-associated contractility changes may warrant caution in cardiac patients; leaves open whether these systolic time interval shifts predict outcomes or apply to newer agents.
The cardiac effects of amitriptyline, mianserin, zimelidine and nomifensine on the systolic time intervals (STI) and on the high speed surface ECG have been studied in depressed patients. Amitriptyline increased pre-ejection period (PEP) index and the PEP/left ventricular ejection time (LVET) ratio of the STI (P less than 0.05 and P less than 0.02). It also increased heart rate significantly (less than 0.02) and tended to prolong Q-T interval. Mianserin shortened QS2I (P less than 0.05) and LVET (P less than 0.01) and prolonged PEP/LVET ratio (P less than 0.01). Zimelidine did not affect the STI but tended to decrease heart rate and prolong the Q-T interval. Nomifensine decreased T wave height. These findings indicate that amitriptyline decreases cardiac contractility and confirm the quinidine-like action of the tricyclic antidepressants. The changes brought about by mianserin are probably due to effects on the peripheral circulation rather than a direct action on the heart.
No takes yet. Share an insight, caveat, or question.
Burgess et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: